"100 first" insulin precursor C-Shengbi radioimmunoassay reagent - Taiwan Registration 8a8b1e15e03f4ef18eff9239fdfb4f9c

Access comprehensive regulatory information for "100 first" insulin precursor C-Shengbi radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8a8b1e15e03f4ef18eff9239fdfb4f9c and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.